Copied And Pasted30 Mar 2023 10:43
Manchester molecular testing business, Genedrive, has confirmed that the UK’s National Institute for Health and Care Excellence (NICE) has ratified and finalised its recommendation that the Genedrive MT-RNR1 ID Kit can be used by the NHS.
The kit can quickly and accurately identify babies with the MT-RNR1 genetic variant who may be at risk of hearing loss if given aminoglycoside antibiotics.
David Budd, Genedrive CEO, said: “We are appreciative of the thorough review conducted by the NICE team. The final report issued today entirely reflects the preliminary conclusion published in February.
“As we continue with commercial roll out and product adoption, the NICE EVA framework will give us the opportunity to support specific performance and impact data that NHS users and commissioners may look for in future guidance.
“NICE, whose guidance is formally applicable to the NHS in England and Wales, is an internationally respected health authority and the tools and data supplied in its review will be relevant to the rest of the United Kingdom and to the other international markets which we are now accessing.”
::
In The Style
Manchester fashion retailer, In the Style, which was sold to a Bidco last week, has had to change its proposed change of name after another company registered the name before it.
It planned to change the new company’s name to Itsum plc, but revealed that, on March 7, Maxrs Ventures Ltd changed its name to Itsum Limited.
Therefore, the company has changed its name to Itsarm plc.
Following the change of name, a new website for the company will be launched in the near future and a further announcement made when the site is launched.
The company’s registered office has also been changed from Salford to 6th Floor, One London Wall, London EC2Y 5EB.
::
Hotter Shoes factory, part of Unbound PLC
Unbound, the parent of Skelmersdale-based Hotter Shoes, has seen its share price recover following the takeover bid launched earlier this week by WoolOvers Group, which is owned by Verdane, a specialist growth equity investor based in Denmark and Sweden.
Shares in Unbound were valued at 4p on March 27, the day before the bid was lodged.
Unbound shareholders were told they would receive 10.5p in cash and one contingent value right per Unbound share, valuing the business at a premium of approximately 162.5% to the Unbound closing share price of 4p per share.
Shares in Unbound closed last night (March 29) at 8.50p, valuing the company at £5.54m.
Its yearly high was 39.03p per share, while its low was 3p.
Click here to sign up to receive our new South West business news...
Previous Article
Next Article
More articles in Business news
Government backs green energy projects in North West – Nuclear...
30/03/2023 MICHAEL TAYLOR
BUSINESS NEWS
THG shareholder urges action on undervalued shares
MICHAEL TAYLOR
BUSINESS NEWS
North West business briefs: Bibby Financial Services; The Plaz
Sign In
Follow the stocks
